分子医学所现有研究员的研究领域与经历介绍
一、Principal Investigator:肖瑞平(Rui-Ping Xiao)
Personal
Synopsis

Rui-Ping (Ping) Xiao was
trained as a cardiologist and physiologist at Tong-Ji
Medical University in Wuhan, China and
the Medical School at University of Maryland at Baltimore (UMAB), where
she earned her M.D. in 1984 and Ph.D. in 1995, respectively. She
joined the Laboratory of Cardiovascular Science, National Institute of Aging,
in 1990 as a postdoctoral fellow, and later in 1996 became a tenure-track investigator
and the head of the Receptor Signaling Unit. In 2004, she was converted to
Senior Investigator at National Institute of
Research
Interest
The scope of her
research work covers three intertwined programs: (I) b-adrenergic receptor subtype
signaling in cardiovascular system; (II) Modulation of cardiac
excitation-contraction coupling by Ca/calmodulin-dependent
protein kinase II (CaMKII)
in normal and failing hearts; and (III) Identification and
characterization of cardiovascular disease-related genes. Her main scientific focus has been G-protein
coupled receptor (GPCR) signaling in the cardiovascular system. Using interdisciplinary
approaches, including physiological and pharmacological techniques in
conjunction with genetic manipulations (e.g. gene-targeted animal models
or adenoviral gene transfer systems), her work revealed dual coupling
of b2-adrenergic receptor (b2AR) with two functionally
opposite G-protein families, Gs and Gi proteins. This
counterintuitive finding was the first demonstration that a given GPCR can
couple to more than one class of G-proteins in a physiological
context such as in intact cardiac myocytes.
Dr. Xiao’s research has demonstrated that
the additional Gi coupling creates a microscopic
compartmentalization of the concurrent Gs-cAMP
signaling and, more importantly, dictates the opposing outcomes of bAR subtype stimulation with respect to
cardiac cell survival and apoptotic cell death.
Dr. Xiao envisioned and promoted the
perception that b1AR and b2AR
subtypes play distinctly different-even opposing-roles in the context of heart
failure. Specifically, while b1AR is widely recognized as a
"foe," b2AR might be a "friend" in need
due to its concurrent anti-apoptotic effect and contractile support. This
new perception of bAR signal
transduction has been increasingly appreciated in the cardiovascular research
community and provides a novel rationale for new therapeutic strategies,
particularly a combination of b1AR blockade with b2AR
activation for improving the function of the failing heart.
Dr. Xiao’s research has not been limited to G protein-coupled
receptor signaling. She was also the first to
characterize role of CaMKII in regulating cardiac
L-type Ca2+ currents and in the control of cardiac pacemaker
activity. Her recent in vivo and in vitro studies have
shown that activation of p38 MAPK exhibits a potent inhibitory effect on
cardiac contractility. In addition,
She has put considerable efforts to understand
mechanisms underlying cardiac aging and heart failur.
Human Genome Project has demonstrated that the family
of G protein coupled receptors (GPCRs) is the largest
gene family in human genome. The GPCR superfamily has
also long been considered the most important target in the pharmaceutical
industry. Remarkably, 70% of today’s therapeutic agents used for the treatment
of cardiovascular diseases are targeted at GPCR signaling pathways.
Thus, one of Dr. Xiao’s major future directions
will be focused on identification and target validation of orphan GPCRs .
These studies will not only provide novel insights into
basic mechanisms of novel GPCRs actions, but
also reveal new rationales for ligand screens as well
as clinical applications. Additionally, identification and
characterization of cardiovascular disease-related genes is another new
initiative of Dr. Xiao’s lab.
Selected
Publuications
1. Xiao, R.P., and Lakatta,
E.G.: b1-adrenoceptor
stimulation and b2-adrenoceptor stimulation differ in their
effects on contraction, cytosolic calcium, and
calcium current in single rat ventricular cells. Circ. Res. 73:
286-300, 1993.
2. Xiao, R.P., Spurgeon, H.A., O'Connor, F., and Lakatta, E.G.: Age-associated changes in b-adrenergic modulation on rat cardiac
excitation-contraction coupling. J. Clin. Invest.
94: 2051-2059, 1994.
3. Xiao, R.P., Cheng, H., Lederer,
W.J., Suzuki, T., and Lakatta, E.G.: Dual regulation
of Ca2+/calmodulin-dependent Kinase II
activity by membrane voltage and by calcium influx. Proc. Nat. Acad., Sci.
4. Xiao, R.P., Hohl, C., Altschuld, R., Jones, L., Livingston, B., Ziman, B., Tantini, B., and Lakatta, E.G.: b2-adrenergic receptor-stimulated increase in cAMP in rat heart cells is not coupled to changes in Ca2+
dynamics, contractility, or phospholamban phosphorylation. J.
Biol. Chem. 269: 19151-19156, 1994.
5. Xiao, R.P., Ji, X.,
and Lakatta, E.G.: Functional coupling of the b2-adrenoceptor to a pertussis
toxin-sensitive G protein in cardiac myocytes. Mol. Pharmacol.
47: 322-329, 1995.
6. Altschuld, R.A., Starling, R.C., Hamlin, R.L.,
Hensley, J., Castillo, L., Fertel, R.H., Hohl, C.M., Robitaille, P.M., Jones, L.R., Xiao,
R.P., and Lakatta, E.G.: Response of failing canine and human
heart cells to b2-adrenergic stimulation. Circulation. 92: 1612-1618, 1995.
7. Xiao, R.P., Pepe, S., Capogrossi, M.C., Spurgeon, H.A., and Lakatta,
E.G.: Opioid peptide receptor stimulation reverses b-adrenergic effects in rat heart
cells. Am. J. Physiol. 272: H797-H805, 1997.
8. Pepe, S., Xiao,
R.P., Hohl, C., Altschuld,
R., and Lakatta, E.G.: "Cross-talk" between
opioid peptide and b-adrenergic receptor signaling in rat heart. Circulation
95: 2122-2129, 1997.
9. Xiao, R.P., Valdivia,
H.H., Bogdanov, K., Valdivia,
C., Lakatta, E.G., and Cheng, H.: The Immunophilin FK506 binding protein (FKBP)
modulates Ca2+ release channel
closure in rat heart cells. J.
Physiol. 500: 331-342, 1997.
10. 18. Zhou,
Y.Y., Cheng, H., Bogdanov, K., Hohl,
C., Altschuld, R., Lakatta,
E.G., and Xiao R.P.:
Localized cAMP-dependent pathway mediates b2-adrenergic stimulation in rat ventricular myocytes. Am. J. Physiol. 273:
H1611-1618, 1997.
11. Xiao, R.P., Tomhave,
E.D., Ji, X., Boluyt, M.O.,
Cheng, H., Lakatta,
E.G., and Koch, W.J.: Age-associated reductions in cardiac b1- and b2-adrenoceptor responses without changes in
inhibitory G proteins or receptor kinases. J. Clin. Invest. 101: 1273-1282, 1998.
12. Xiao, R.P., Avdonin,
P., Zhou, Y.Y., Cheng, H.,
13. Kuschel,
M., Bartel, S., Spurgeon, H.A., Zhou, Y.Y., Zhang,
S.J., Krause, E.G., Lakatta, E.G., and Xiao, R.P.: Canine cardiac b2-adrenergic signaling is localized to the sarcolemma membrane.
Circulation 99:2458-2465,
1999.
14. Kuschel, M., Zhou, Y.Y., Cheng, H., Zhang, S.J.,
Chen-Izu, Y., Lakatta,
E.G., and Xiao, R.P.: Gi
protein-mediated functional compartmentalization of cardiac b2-adrnergic signaling. J. Biol. Chem. 274:
22048-22052, 1999.
15. Zhou, Y.Y., Cheng, H., Song, L.S., Lakatta, E.G., and Xiao,
R.P.: Differential regulation of cardiac L-type calcium channel current by
constitutively active and agonist-activated b2-adrenergic
receptor signaling. Mol. Parmacol. 56: 485‑93, 1999.
16. Xiao, R.P., Cheng, H., Zhou, Y.Y., Kuschel, M., and Lakatta, E.G.:
Recent advances in cardiac b-adrenergic
receptor subtype signal transduction.
Circ. Res. 85:1092-1100, 1999
(Invited Review).
17. Zhou, Y.Y., Song, L.S., Lakatta,
E.G., Xiao, R.P., and Cheng, H.:
Constitutive b2-adrenergic signaling enhances SR calcium to augment
contraction in mouse heart. J. Physiol. 521:
351-363, 1999.
18. Zhang, S.J., Cheng, H., Zhou, Y.Y., Wang,
D.J., Zhu, W., Ziman, B.,
Spurgeon, H., Lefkowitz, R.J., Lakatta,
E.G., Koch, W.J., and Xiao, R.P.:
Inhibition of spontaneous b2-adrenergic activation rescues b1-adrenergic contractile response in cardiomyocytes overexpressing b2-adrenoceptor.
J. Biol. Chem. 275: 21773-21779, 2000.
19. Hagemann, D., Kuschel,
M., Kuromochi, T., Zhu, W., Cheng, H., and Xiao, R.P.: Frequency-encoding Thr17
phospholamban phosphorylation
is independent of Ser16 phosphorylation in
cardiac myocytes. J.
Biol. Chem. 275: 22532-22536, 2000.
20. Vinogradova, T.M., Zhou, Y.Y., Bogdanov,
K.Y., Kuschel, M., Cheng, H., and Xiao, R.P.: Sinoatrial
node pacemaker activity requires Ca2+/calmodulin-dependent protein kinase II activation. Circ.
Res. 87: 760-767, 2000.
21. Xiao, R.P.: Cell logic for dual coupling of a
single class of receptors to Gs and Gi
proteins. Cric. Res. 87:635-637, 2000
(Editorial).
22. Zhou, Y.Y., Zhu, W., Zhang, S..J., Wang, D.J., Kobilka, B., Lakatta, E.G., Cheng, H., and Xiao, R.P.: Ligand-independent activation
of b2- but not b1-adrenoceptor overexpressed
in b1/b2-adrenoceptor double knockout mouse cardiomyocytes. Mol. Pharmacol. 58: 887-894, 2000.
23. Zheng, M., Zhang, S.J., Zhu, W., Ziman, B., Kobilka, B.K., and Xiao, R.P.: adrenergic receptor-induced
p38 MAPK activation is mediated by PKA rather than by Gi
or Gb( in adult mouse cardiomyocytes. J.
Biol. Chem. 275: 40635-40640, 2000.
24. Zhu, W.Z., Zheng,
M., Lefkowitz, R.J., Koch, W.J., Kobilka,
B., and Xiao, R.P.: Dual modulation
of cardiac cell survival and cell death by b2-adrenergic
signaling in adult mouse heart cells. Proc.
Nat. Acad., Sci. USA 98:
1607-1612, 2001.
25. Xiao, R.P.: β-adrenergic signaling in the heart: Dual
coupling of the β2-adrenergic receptor to Gs and Gi proteins. Science’s STKE. 16:RE15,
2001 (invited Review).
26. Liao, P., Wang, S.Q., Zheng,
M., Zheng, M.Z., Cheng, H., Wang, Y., and Xiao, R.P.: p38 mitogen
activated protein kinase mediates negative inotropic effect in cardiac myocytes. Circ.
Res. 90:190-196, 2002.
27. Jo, S.H., Leblais, V., Crow, M.T., and Xiao, R.P.: Phosphatidylinositol 3-kinase
functionally compartmentalizes the concurrent Gs signaling during b2-adrenergic stimulation. Circ. Res. 91: 46-53, 2002.
28. Zhu, W.Z., Wang, S.Q., Chakir,
K., Kolbilka, B.K., Cheng, H., and Xiao, R.P.: Linkage of b1-adrenergic stimulation to apoptotic heart
cell death through protein kinase A-independent
activation of Ca2+/Calmodulin Kinase II. J.
Clin. Invest. 111:617-625, 2003.
29. Xiao, R.P., Zhang, S.J. Kuschel,
M., Zhou, Y.Y., Bond, R.A., Balke, C.W., Lakatta, E.G., and Cheng, H.: Enhanced Gi
signaling mediates the diminution of b2-adrenergic contractile response in failing
spontaneous hypertensive rat heart. Circulation. 108:1633-1639, 2003.
30. Chakir, K., Xiang, Y.,
Zhang, S.J., Yang, D., Cheng, H., Kobilka, B.K., and Xiao, R.P.: The third intracellular loop and the carboxyl terminus of b2-adrenergic receptor confer the receptor
spontaneous activity. Mol. Pharmacol. 64:1048-58, 2003.
31. Xiao,
R.P., and Balke, C,W,: Na+/Ca2+
Exchange Linking b2-Adrenergic Gi
Signaling to Heart Failure: Associated Defect of Adrenergic Contractile
Support. J Mol. Cell. Cardiol. 36:7-11,
2004, (Editorial).
32. Ding, J.H., Xu,
X., Yang, D., Chu, P.H., Dalton, N.D., Ye, Z., Yeakley, J.M., Cheng, H., Xiao, R.P., Ross, J.,
Chen, J., and Fu, X.D.: Dilated cardiomyopathy caused
by tissue-specific ablation of SC
33. Patterson, A.J., Zhu, W., Chow, A., Kosek, J., Xiao, R.P., and Kobilka,
B.K.: Protecting the myocardium: A
role for the b2-Adrenergic receptor in the heart. Critical Care Medicine. 32:1041-8,
2004.
34. Xiao, R.P., Zhu, W., Zheng, M.,
Bond, R., Lakatta, E.G., and Cheng, H.: Subtype-specific b-adrenergic signaling pathways and their clinical implications.
Trends in Pharmacological Sciences (TiPS).
25: 358-365, 2004, (invited Review).
35. Pepe, S., van den Brink, O.W.V., Lakatta, E.G., and Xiao,
R.P.: b-Adrenergic Receptor-Opioid
Peptide Receptor Cross-talk: Cardiovascular Regulation and Adaptation in Health
and Disease. Cardiovascular Research. 15;63:414-22,
2004, (invited Review).
36. Chen, K.H., Guo,
X.M., Ma, D.L., Guo, Y.H., Li, Q., Li, P., Qiu, X., Xiao*, R.P., & Tang, J.: Dysregulation
of A Novel Hyperplasia Suppressor Gene Triggers
Vascular Proliferative Disorders. Nature Cell Biology, 6:872-83,
2004, (*the
corresponding author).
37. Leblais, V., Jo, S.H., Chakir,
K., Maltsev, V., Zheng, M.,
Crow, M.T., Wang, W., Lakatta, E.G., & Xiao,
R.P. Phosphatidylinositol 3-Kinase Offsets cAMP-Mediated Positive Inotropic
Effect via Inhibiting Ca2+ Influx in Cardiomyocytes. Circ. Res., 2004, 95:1183-90.
38. Zheng, M., Jo, S.H., Wersto, R., Han, Q., and Xiao, R.P.: Intracellular
Acidosis-Induced p38 MAPK Activation and Its Pathophysiological
Relevance in Cardiomyocyte Ischemia. FASEB J. 2005, 19:109-11.
二、Principal Investigator:程和平(He-ping Cheng)
Personal
Synopsis

Heping
(Peace) Cheng received degrees in applied mathematics and mechanics,
physiology, and biomedical engineering from
Research
Interest
In my early years at
As a Ph.D. student at the
In my first English publication, my co-workers and I reported the discovery of "Ca2+ sparks" as the elementary events of intracellular Ca2+ signaling. Ca2+ sparks are brief openings of variable cohorts of from one to eight ryanodine receptor (RyR) Ca2+ release channels in the endoplasmic or sarcoplasmic reticulum (ER or SR). The summation of coordinated activation of Ca2+ sparks in space and time gives rise to complex global Ca2+ signals.
Subsequent research in "sparkology" has unraveled exquisite hierarchal architecture of Ca2+ signaling. On the basis of these findings, we have proposed that Ca2+ signaling is, in essence, a discrete, stochastic, and digital system, rather than a continuous, deterministic, analog system, as previously thought. This concept not only sheds new light on calcium’s complex simplicity, but also allows for unprecedented precision in the detection and definition of disease-related aberrant Ca2+ signaling.
In collaboration with M.T. Nelson, we uncovered a novel Ca2+ signaling pathway in which sparks relax vascular smooth muscles. In this pathway, subsurface sparks activate large-conductance Ca2+-sensitive K+ channels, which shut off L-type Ca2+ influx through hyperpolarization of the membrane. This leads to reduction of intracellular Ca2+ and muscle relaxation. This finding vividly illustrates that a single simple messenger, Ca2+, can serve different and even opposing roles in the same cell.
In heart muscle cells, Ca2+ entering through L-type Ca2+ channels traverses a 12-nm junctional cleft to activate RyRs in the SR, liberating stored Ca2+. This process is known as Ca2+-induced Ca2+ release (CICR). For years, many physiologists dreamed of "seeing" nanoscale, intermolecular CICR. Our team has now painstakingly accomplished the optical recording of single L-type channel Ca2+ currents or "Ca2+ sparklets." We went on to demonstrate that a single sparklet can trigger a spark in an all-or-none fashion. These steps made it possible to define the stoichiometry, kinetics, and fidelity of intermolecular signaling in real time and in live cells.
Most recently, we found that when a spark ignites, rapid and substantial decreases in Ca2+, called "Ca2+ blinks," develop within nanometer-sized stores—the junctional cisternae of the SR. The complementary spark-blink signal pairs in heart may be a prototype for similar reciprocal signals and suggest space-time organization of signaling from Ca2+ stores, including capacitive Ca2+ entry and ER/SR-dependent apoptotic signaling.
The aims of our current and future Ca2+ signaling research are to discover new phenomena, functions, and mechanisms—leading to new concepts and theories—as we develop novel methods, analytic tools, special reagents, and instruments for Ca2+ studies. We hope these "nuts and bolts" will broaden the frontier of technology for the field.
We will continue to focus on Ca2+ signaling in subcellular compartments and organelles (mitochondria, ER/SR, and nuclei) and in vivo imaging of biosensors at single-cell and single-molecule resolutions. But beyond this, we will consider the Ca2+ signalome as a whole, including synthesizing information gleaned from molecules, pathways, subcellular organelles, cells and organisms. This integration enlists the powerful addition of bioinformatics and system theory to our current research portfolio. In addition, through collaboration, we also hope to translate our findings to pertinent disease models, thereby advancing the understanding of the etiology and enlightening the treatment of human diseases.
Selected
Publuications
1. Cheng, H., Lederer,
W.J., Cannell., M.B., 1993, Calcium sparks: The elementary events
underlying excitation-contraction coupling in heart muscle. Science 262,
740-744
2. Cheng, H., Lederer,
W.J., Cannell, M.B., 1995, Partial inhibition of
calcium current by D600 reveals spatial non-uniformities in [Ca2+]i during
excitation-contraction coupling in cardiac myocytes. Circ.
Res. 76, 236-241
3. Cheng, H., Fill, M., Valdivia,
H.H., Lederer, W.J., 1995, Models of calcium release
channel adaptation, Science 267, 2009-2010
4. Cannell, M.B., Cheng, H., Lederer, W.J., 1995, The control
of calcium release in heart muscle.
Science 268, 1045-1050
5. Nelson, M.T., Cheng, H., Rubart, M., Santana, L.F., Bonev,
A., Knot, H., Lederer, W.J., 1995, Relaxation of arterial smooth
muscle by calcium sparks. Science 270, 633-637
6. Klein, M.G., Cheng, H.*,
Santana, L.F., Lederer, W.J., Schneider, M.F., 1996,
Discrete sarcomeric calcium release events activated
by dual mechanisms in skeletal muscle. Nature 379, 455-458 (* the
corresponding author)
7. Gomez, A.M.,
8. Sham, J., Song, L.-S., Deng, L.H., Chen-Izu, Y., Lakatta, E.G., Stern,
M.D., Cheng, H., 1998,
Termination of Ca2+ release by local inactivation of ryanodine receptors in cardiac myocytes.
Proc. Natl. Acad. Sci. USA 95, 15096-15101
9. Shirokova, N., Gonzalez, A., Kirsch, W.G., Rios,
E., Pizarro, G.,
Stern, M.D., Cheng, H., 1999, Calcium sparks: release
packets of uncertain origin and fundamental role. J. Gen. Physiol. 113, 377-384 (Invited Review)
10. Wang, S.Q., Song, L.-S., Lakatta, E.G., Cheng, H., 2001, Ca2+ signalling between single L-type Ca2+ channels
and ryanodine receptors in heart cells. Nature 410,
592-596
11. Song, L.-S., Wang, S.Q., Xiao,
R.-P., Spurgeon, H., Lakatta, E.G., Cheng, H.,
2001, b-adrenergic stimulation synchronizes intracellular Ca2+
release during excitation-contraction coupling in cardiac myocytes. Circ. Res. 88, 794-801
12. Song, L.-S., Guia,
A., Muth, J., Rubio, M., Wang, S.Q, Xiao, R.-P., Josephson,
I.R., Schwartz, A., Lakatta, E.G., Cheng, H.,
2002, Ca2+ signaling in
cardiac myocytes overexpressing
the α1-subunit of L-type Ca2+ channel. Circ. Res. 90,
174-181
13. Pan, Z., Yang, D., Nagaraj, R.Y., Nosek, T.A.,
Nishi, M. Takeshima, H., Cheng, H., Ma, J.,
2002, Dysfunction of store-operated Ca2+ channel in muscle cells
lacking mg29 gene. Nature Cell Biol. 4, 379-383
14. Yang, D., Song, L.-S., Zhu, W.Z., Chakir, K., Wang, W., Wu, C., Wang, Y., Xiao, R.-P., Chen,
S.R.W., Cheng, H., 2003, Calmodulin regulation
of excitation-contraction coupling in cardiac myocytes.
Circ. Res. 92, 659-667
15. Wang, S.Q., Stern,
M.D., Ríos, E., Cheng, H., 2004,The quantal nature of ca2+
sparks and in situ operation of the ryanodine
receptor array in cardiac cells. Proc. Natl. Acad. Sci. USA 101, 3979-3984
16. Wang, S.Q., Wei,
C.L., Gao, G. L., Brochet,
D., Shen, J.X., Song, L.S., Wang, W., Yang, D.M., Cheng,
H., 2004, Imaging microdomain Ca2+ in
muscle cells. Circ. Res. 94, 1011-1022 (invited review)
17. Wang, W., Zhu, W., Wang, S. Q.,
Yang, D. M., Crow, M. T., Xiao, R. P., Cheng, H., 2004, Sustained
b1-adrenergic stimulation modulates cardiac
contractility by Ca2+/calmodulin kinase
signaling pathway. Circ. Res.
95,798-806.
18. Brochet, D. X. P., Yang, D., Di Maio, A., Lederer, W. J., Franzini-Armstrong, C., Cheng, H., 2005, Calcium
blinks: Rapid nanoscopic store calcium signaling. Proc.
Natl. Acad. Sci. USA, 102, 3099-3104
19. Ouyan, K., Wu, C. H., Cheng, H. (2005) Ca2+-induced Ca2+
release in sensory neurons: Low-gain amplification confers intrinsic stability.
J. Biol. Chem. 280, 15898-15902
三、Principal Investigator:周专( Zhuan Zhou)
Personal
Synopsis

Zhuan
Zhou, 1984, B.S. Electronic instrumentation,
Research
Interests
Secretion is a principle function of a cell. Neurotransmitter and hormone secretion
is triggered by increase in intracellular Ca concentration. We are interested in mechanisms of how
intracellular Ca is regulated in single cell level by advanced methods
including electrophysiological and optical fluorescence measurements. We
investigate mechanisms of neurotransmitter, in particular catecholamines,
release from soma (or synapse) of a cell by patch-clamp, membrane capacitance
and carbon fiber electrodes (CFEs) and fluorescent
optic measurements. We are
interested in creating/modifying biophysical technologies for advanced
experiments including Ca homeostasis, patch-clamp and
stimulus-secretion-coupling. Our
goal is to best understand how secretion is regulated in a living cell, and how
catecholamine release (from adrenal chromaffin cells as well as catechonminergic
CNS neurons, affect cardiac/vesicular function.
Ionic channels,
action potentials and quantal secretion in single
cells
Neurotransmitter
release is primary triggered by Ca influx during action potentials in neuronal
cells. Action potentials are generated and regulated by variety of ion channels
on the cell membrane. We are interested in how action potential patterns are
regulated by the ion channels, and how secretion is regulated by different
encodes of the action potentials. We created a technique for membrane
capacitance measurements using reconstituted codes of action potentials as
stimulation protocol and we are studying the relation between action potential
pattern and cell secretion in chromaffin cells.
We are interested in the kinetics of fusion pore, which
release/uptake vesicle contents during an exocytotic/endocytotic
event. In adrenal chromaffin cells, we discovered that the endogenous
transmitter ATP can inhibits secretion via two pathways: Ca channel (50% of
total inhibition) and fusion pore (the other 50% of total inhibition). ATP reduces the fusion pore open time or
shift the mode of exocytosis to “kiss-and-run”. In astrocyte,
a hippocampal glia, we
study Ca dependent quantal secretion as well. In particular, the fusion pore kinetics
in astrocytes is distinct in response to different
stimulations.
Ion channels are molecular basis for action
potentials. Ion channels studies in our lab including Na channel
(inactivation), voltage and Ca dependent K channels (specific toxins against BK
and SK channels) and HCN pacemaker channels. The role of HCN (or If,
Ih) channels is to generate rhythmic
action potentials in the host cells.
In opposite to other voltage gated channels, these channels activate at
negative potentials and thus depolarize the cell to fire next Na dependent
action potential. This
non-selective cation channel has a reversal potential
at –30-40 mV and permeates Na+ and K+. Recently, we discovered that in addition
to mono cation, HCN can permeate Ca2+ as
well: 05% of total current is contributed by Ca2+. The Ca influx through Ih channels can modulate neuronal secretion in
DRG neurons and action potential duration in cardiac cells.
In sensory dorsal
root ganglion (DRG) neurons, we have discovered a novel type of action potential
triggered secretion in the soma, Ca independence but voltage dependent secretion
(CIVDS). This means, depolarization
can directly trigger exocytosis in the absence of
both internal and external Ca2+. This finding was very surprising in
the areas of stimulus-secretion coupling and synaptic transmission, because the
dominant “Ca hypothesis” puts Ca2+ as the only trigger for exocytosis, the role of voltage depolarization is only to
allow Ca influx through voltage gated Ca channels. CIVDS can be detected by
membrane capacitance, electrochemical amperometry,
and confocal single vesicle imaging assays. In DRG soma, membrane
depolarization/action potential trigger both Ca
dependent secretion (CDS) and CIVDS.
Vesicle pool size of CIVDS is 20 % of that of CDS. After depletion of
the, the recovery rate of the vesicle pool of CIVDS is fast (10 s). Compared
with CDS, the onset rate of CIVDS is very fast. The voltage dependence of CIVDS is
similar as a voltage-sensitive ion channel. These properties make CIVDS to be the
major source of secretion in response to in low (< 5 Hz) frequency action
potentials.
Under
physiological conditions, the low frequency of action potential may trigger
Following CIVDS, there is a rapid endocytosis
termed CIVDS-RE. Compared to other endocytosis in neurons, CIVDS-RE has several distinct
properties: (1) like CIVDS, RE is Ca independent; (2) RE is dynamin
independent; (3) RE depends on frequency of action potentials; (4) RE is
dependent of PKA, which is activated by high (not low) frequency of action
potentials.
In addition to voltage-triggered exocytosis
and endocytosis, we are interested in ligand-triggered exocytosis and endocytosis.
Compared to Ca2+ influx through Ca channels, the caffeine
sensitive Ca stores (or Ca sparks) alone have a lower efficiency to trigger
secretion. However, Ca stores provide an important synergistic role to enhance
depolarization induced secretion.
Finally, we are studying ligand-induced endocytosis and their signal tranduction
with high spatial and temporal resolution by using capacitance and single
vesicle imaging. These studies may have potential applications in GPCR-mediated
signaling in neurons and cardiac cells.
Stimulus-secretion-coupling between neurons in the brain
slice and in living brain
Currently,
majority studies on stimulus-secretion-coupling are performed in culture
cells. This is because the culture
cells offer relative simple techniques to record secretion in single cells. However, interaction between neurons and
other cell environment maintain better in brain slice or in vivo. To understand how synaptic transmission
and cell secretion occur in brain slice and/or in vivo, we are developing new carbon
fiber electrodes (CFEs) and studying neurotransmitter
release in slice and in living animals.
We determine the common and different features of stimulus-secretion coupling
between neurons in culture, in slice and in vivo. These studies may lead new
insights into exocytosis/endocytosis in response to
stimuli under more physiological conditions.
Development of novel microprobes to detect neuropeptides secretion from single cells with high
spatial-temporal sensitivity
Neuropeptides are important modulators for fundamental brain functions. Unlike other ligands such as ACh, glutamate etc, there are few neuropeptide-gated ion channels, which can be recorded by patch-clamp. Thus, to detect neuropeptide new probes are needed. Since several years we are working on new types of electrodes, which may sense release of neuropeptides. Our goal is to use the new peptide-electrodes to study how, when and where neuropeptides are released from culture single cells, brain slices and living brains.
.
Selected
Publuications
1. Chen Zhang, Wei Xiong, Hui Zheng, Liecheng Wang, Bai Lu and Zhuan Zhou (2004) Calcium- and dynamin-independent endocytosis in dorsal root ganglion neurons. Neuron, 42: 225–236
2. Yu X, Duan KL, Shang CF, Yu HG and Zhou Z (2004) Calcium influx through hyperpolarization-activated cation channels ( Ih channels) contributes to activity-evoked neuronal secretion. Proc Natl Acad Sci U S A., 101:1051-1056.
3. Duan KL, Yu X, Zhang C, and Zhou Z (2003) Control of Secretion by Temporal Patterns of Action Potentials in Adrenal Chromaffin Cells. J. Neurosci., 23(35):11235-43
4. Xuelin Lou, Xiao Yu, Xiao-Ke Chen, Liming He, Kai-Lai Duan, Anlian Qu, Tao Xu and Zhuan Zhou. (2003) Na channel inactivation: a comparison study between pancreatic islet ß-cells and adrenal chromaffin cells in rat. J. Physiol (Lond) 548: 191-202.
5. Chong-Xu Fan, Xiao-Ke Chen, Chen Zhang, Li-Xiu Wang, Kai-Lai Duan, Lin-Lin He, Ying Cao1, Shang-Yi Liu, Ming-Nai Zhong, Chris Ulens, Jan Tytgat, Ji-Sheng Chen, Cheng-Wu Chi and Zhuan Zhou. (2003) A Novel Conotoxin from Conus betulinus, k-BtX, unique in Cysteine Pattern and in Function as a specific BK Channel Modulator. J. Biol. Chem. 278:12624-33
6. Lan Bao, Shan-Xue Jin, Chen Zhang, Li-Hua Wang, Zhen-